Esophageal or Gastroesophageal Junction EA2174

A Phase II / III Study of Peri-Operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

Back To Clinical Trials NCI Database Entry